Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study
- PMID: 15293286
- DOI: 10.1002/ana.20197
Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study
Abstract
In 2001, we followed up all patients from the 1991 Olmsted County Multiple Sclerosis (MS) prevalence cohort. We found that the longer the duration of MS and the lower the disability, the more likely a patient is to remain stable and not progress. This is particularly powerful for patients with benign MS with Expanded Disability Status Scale score of 2 or lower for 10 years or longer who have a greater than 90% chance of remaining stable. This is important because these patients represent 17% of the entire prevalence cohort. These data should assist in the shared therapeutic decision-making process of whether to start immunomodulatory medications.
Copyright 2004 American Neurological Association
Similar articles
-
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.Neurology. 2005 Apr 12;64(7):1144-51. doi: 10.1212/01.WNL.0000156155.19270.F8. Neurology. 2005. PMID: 15824338
-
Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.J Neurol Sci. 2005 May 15;232(1-2):65-9. doi: 10.1016/j.jns.2005.01.008. J Neurol Sci. 2005. PMID: 15850584
-
Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population.Mov Disord. 2004 Dec;19(12):1482-5. doi: 10.1002/mds.20227. Mov Disord. 2004. PMID: 15390075
-
The natural history of multiple sclerosis.Neurol Sci. 2000;21(4 Suppl 2):S815-7. doi: 10.1007/s100720070018. Neurol Sci. 2000. PMID: 11205355 Review.
-
The natural history of multiple sclerosis.Can J Neurol Sci. 1987 Aug;14(3):255-61. doi: 10.1017/s0317167100026573. Can J Neurol Sci. 1987. PMID: 3311324 Review.
Cited by
-
Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis.Curr J Neurol. 2021 Jul 6;20(3):154-161. doi: 10.18502/cjn.v20i3.7691. Curr J Neurol. 2021. PMID: 38011445 Free PMC article.
-
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.Neurol Sci. 2016 Aug;37(8):1261-70. doi: 10.1007/s10072-016-2578-x. Epub 2016 Apr 20. Neurol Sci. 2016. PMID: 27095052
-
Natural history of multiple sclerosis symptoms.Int J MS Care. 2013 Fall;15(3):146-58. doi: 10.7224/1537-2073.2012-053. Int J MS Care. 2013. PMID: 24453777 Free PMC article.
-
A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.J Neurol. 2008 Jul;255(7):1023-31. doi: 10.1007/s00415-008-0827-5. Epub 2008 Jun 13. J Neurol. 2008. PMID: 18535872
-
Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up.Neurol Sci. 2016 Sep;37(9):1457-65. doi: 10.1007/s10072-016-2604-z. Epub 2016 May 13. Neurol Sci. 2016. PMID: 27177651
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical